Main > A1. CORP. INDEX. An-Az > AstraZeneca/P C2
This data is not available for free
AstraZeneca/P C2's subsections
2001. 05.09.2001. (Psychiatry)
2002. 02.12.2002. (Supplier)
2002. 04.--.2002. (Chagas D.)
2002. 04.01.2002. (GastroEnt.)
2002. 04.24.2002. (GastroEnt.)
2002. 05.13.2002. (Onco.
2002. 05.20.2002. (Onco.)
2002. 07.08.2002. (Rhodia ChiRex)
2002. 09.03.2002. (Cardio.)
2002. 09.23.2002. (GastroEnt.)
2002. 12.02.2002. (GastroEnt.)
2002. 12.02.2002. (Market Share)
2002. 12.02.2002. (Neurology)
2002. 12.02.2002. (Supplier)
2003. 01.27.2003. (Executive)
2003. 01.27.2003. (Neuro.)
2003. 01.27.2003. (Onco.)
2003. 02.17.2003. (Onco.)
2003. 03.17.2003. (Cardio.)
2003. 03.17.2003. (GastroEnt.)
2003. 03.17.2003. (Onco.)
2003. 03.17.2003. (Ranking)
2003. 03.17.2003. (Sales)
2003. 05.19.2003. (Executive)
2003. 05.19.2003. (Systems Biology)
2003. 05.26.2003. (Blood Coag.)
2003. 06.02.2003. (Divestment)
2003. 09.11.2003. (Cardio.)
2003. 10.16.2003. (Onco.)
2004. 01.08.2004. (Onco.)
2004. 11.22.2004. (Cambridge Ab.)
2005. 01.10.2005. (Onco.)
2005. 07.11.2005. (Cardio.>Avanir)
2006. 01.16.2006. (Ele. NoteBooks)
2006. 03.20.2006. (India)
2006. 08.14.2006. Sr Scientist
2006. 08.28.2006. Exec VP Global
2006. 09.25.2006. Schering AG>Onco.
2007. 01.22.2007. Proc Engg Directo
2007. 04.30.2007. CEO
2007. 04.30.2007. Exec Director Dev
2007. 05.14.2007. Exec. VP Discov.
2007. 06.11.2007. DSM Bio Plant Acq
2007. 06.18.2007. (Process R&D)
2007. 07.23.2007. (Neuro.>AD)
2007. 07.30.2007. Director Asia
2007. 07.30.2007. VP Global Externa
2007. 08.06.2007. Director Science
2007. 08.23.2007. (Neuro.>Schizo.)
2007. 09.24.2007. (Verus Pharma.)
2008. 01.24.2008. (Onco.>Pain)
2008. 02.11.2008. Personalized Med.
2008. 02.27.2008. Onco.>Colon C.
2008. 02.29.2008. Neuro.>MDD
2008. 03.12.2008. Patent Dispute
2008. 03.13.2008. siRNA Drug Deliv.
2008. 06.23.2008. Exec VP Discov.
2008. 09.08.2008. Psychiatry Discov
2008. 09.22.2008. VP Global
2008. 10.20.2008. Diab.
2008. 10.20.2008. NeuroGenesis
2008. 11.03.2008. VP Cancer R&D
2008. 11.10.2008. CV & GI Diseases
2008. 11.10.2008. Exec Director
2008. 11.24.2008. BioMfg Plant Sale
2008. 12.01.2008. CEO In NA
2008. 12.01.2008. Exe VP Operations
2009. 02.09.2009. AntiDepressants
2009. 06.01.2009. Onco.>Merck USA
2009. 08.31.2009. AS; OA; RA
2009. 09.21.2009. Nektar Therap.
2009. 12.03.2009. Targacept
2009. 12.04.2009. Neuro.>Schizo BM
2009. 12.15.2009. Uni. Virginia
2010. 01.18.2010. Dako DK
2010. 03.08.2010. Onco.>Colon C
2010. 03.11.2010. Torrent Pharma
2010. 03.17.2010. Diab.>BMS>S+M
2010. 05.03.2010. TB Alliance
2010. 05.26.2010. Pres. Of R&D
2010. 05.28.2010. Onco.>Colon C.
2010. 06.28.2010. MMV>Malaria
2010. 06.30.2010. Cardio.>HeFH
2010. 07.05.2010. MRC Technology
2010. 09.02.2010. Neuro.>MDD
2010. 10.25.2010. Sepsis
2010. 10.29.2010. Gastro.>GERD
2010. 12.17.2010. NonExec Director
2010. 12.21.2010. Pneumo.>RSV Dis.
2011. 02.01.2011. Influenza Vacc.
2011. 02.02.2011. HealthCore
2011. 02.07.2011. Neuro.>MDD
2011. 02.07.2011. Onco.>Prostate C.
2011. 03.07.2011. Pneumo.>Asthma
2011. 05.24.2011. Onco.>Bone Metas.
2011. 06.16.2011. RU>Predictive
2011. 06.22.2011. Bus. Sale
2011. 07.20.2011. Cardio.>PAI
2011. 08.02.2011. Cardio.>Aspirin
2011. 09.28.2011. Onco.>Breast C.
2011. 09.29.2011. Handa Pharma.
2011. 10.05.2011. Accord Healthcare
2011. 10.18.2011. Infection>cIAI &
2011. 12.05.2011. MRC
2011. 12.08.2011. Acq. CN Generics
2011. 12.15.2011. Cardio.>ACS
2011. 12.20.2011. Neuro.>MDD
2011. 12.21.2011. Onco.>Volitinib
2012. 01.11.2012. IMS Health
2012. 02.21.2012. Onco.>Thyroid C.
2012. 03.01.2012. Chairman
2012. 03.01.2012. Flu Vaccine
2012. 03.08.2012. Acq CN Co.
2012. 03.26.2012. Generic Seroquel
2012. 04.16.2012. Conformetrix Ltd
2012. 05.24.2012. Antibiotics Res.
2012. 06.19.2012. Pneumo.>Asthma
2012. 07.02.2012. Pneumo.>TB
2012. 07.12.2012. Link Medicine
2012. 07.12.2012. Neuro.>AD>A5
2012. 07.17.2012. Cardio.>PAD
2012. 08.09.2012. BMS
2012. 08.16.2012. Regulus Therap.
2012. 08.28.2012. Antibiotics
2012. 08.28.2012. CEO
2012. 09.10.2012. Broad Institute
2012. 10.15.2012. Pharmaron
2012. 10.16.2012. Charles River Lab
2012. 10.23.2012. Ironwood Pharma.
2012. 10.31.2012. MRC
2012. 12.04.2012. UK HSCIC Diab.
2012. 12.11.2012. Isis Pharma.
2012. 12.18.2012. CV.>Fudan Uni.
2013. 01.14.2013. Vanderbilt Uni.
2013. 01.15.2013. Sr. Exec. Team
2013. 02.13.2013. US Foundation
2013. 03.05.2013. AU Patent InValid
2013. 03.21.2013. Karolinska Inst.
2013. 03.21.2013. Moderna Therap.
2013. 04.05. Rheuma.>RA>F
2013. 04.22. Bind Therap.
2013. 04.22. Horizon Discovery
2013. 04.22. Pneumo.>COPD>AZD5423
2013. 04.24. Alchemia
2013. 05.16. Onco.>Pipeline
2013. 05.28. Corp. Acq.
2013. 06.04. Rheuma.>RA>F
2013. 06.17. Diab. & Obesity
2013. 06.26. Roche
2013. 06.28. Corp. Acq.
2013. 07.09. Onco.>Cambridge
2013. 07.10. Cancer Res. UK
2013. 07.17. Tufts Uni.
2013. 07.31. Nephro.>Anemia
2013. 08.26. Acq. Amplimmune
2013. 09.02. Diab.>BMS>S
2013. 09.11. Onco.>Ovarian C. WEE1
2013. 10.15. Onco.>Acq. Spirogen
2013. 10.16. Organs-on-Chips
2013. 10.17. TW>NRPB
2013. 10.24. Close Brixham Lab.
2013. 11.11. Onco.>Prostate C.
2013. 11.19. HQ.>UK>Cambridge
2013. 12.06. Influenza Vaccine
2013. 12.12. LipoDystrophy
2013. 12.19. Diab.>BMS>Acq.
2014. 01.08. Diab.>Dapagliflozin
2014. 01.08. MedImmune & ImmunoCore
2014. 02.17. CRUK Cambridge Inst.
2014. 02.20. USA>Free Medicine
2014. 02.25. LipoDystrophy
2014. 03.03. Diab.>Exenatide ER
2014. 03.11. Sale UK R&D Site
2014. 03.26. JP>AstraZeneca KK
2014. 03.31. MRC
2014. 05.06. CV.>Triglyceride Redn.
2014. 05.08. Onco.>Lung C.>NSCLC>M
2014. 05.12. Rheuma.>RA>M & S
2014. 05.15. MRC LMB
2014. 06.11. Diab.>ADA
2014. 06.12. Pneumo.>Asthma>IFN
2014. 07.03. MRC Technology
2014. 07.08. Max Planck Institute
2014. 07.22. MedImmune & Advaxis
2014. 07.22. UK researchers
2014. 07.28. Onco.>Lung C.>NSCLC>A
2014. 07.28. Onco.>Lung C.>NSCLC>I
2014. 07.30. Acq. Almirall Asthma &
2014. 07.30. Kyowa Hakko Kirin
2014. 08.13. Gout
2014. 08.14. Pneumo.>Asthma>MAb
2014. 08.21. Illumina
2014. 09.08. Pneumo.>COPD>MAb
2014. 10.16. Uni. Cambridge
2014. 10.30. Diab.>Dapagliflozin+M.
2014. 11.04. Acq. Definiens
2014. 11.04. Onco.>Pharmacyclics
2014. 11.13. AntiPlatelet Reversal
2014. 12.01. Neuro.>AD
2014. 12.09. Gastro.>OIC
2015. 01.29. CRISPR 4 Deals
2015. 02.05. Acq. Actavis s Branded
2015. 02.25. Orca Pharma.
2015. 02.26. Antibiotic R&D
2015. 04.13. PatientsLikeMe
2015. 04.24. Celgene
2015. 05.18. SE Biologics Plant
2015. 07.09. EvoRx Technologies
2015. 07.27. Onco.>Thyroid C.
2015. 08.03. Isis Pharma.
2015. 08.06. Heptares Therapeutics
2015. 08.10. Inovio Pharma.
2015. 09.03. CV.>Heart Attack
2015. 11.06. Acq. ZS Pharma.
2015. 11.13. Onco.>Lung C.>NSCLC>T
2015. 11.20. Sanofi
2015. 12.11. WCPR>Secretome
2015. 12.16. Wuxi AppTec
2015. 12.17. Onco.>Acerta Pharma
2015. 12.22. Gout
2016. 03.02. Onco.>Breast C.
2016. 04.22. Genomics
2016. 05.03. Onco.>Ovarian C. PARP
2016. 06.28. bacterial infections
2016. 07.01. Derma.>Leo Pharma
2016. 07.11. Onco.>Lung C.>NSCLC>T
2017. 02.28. Diab.>Dapagliflozin+S
2017. 03.03. Pneumo.>MEDI8897>RSV
2017. 03.27. Onco.>Lung C.>NSCLC>T
2017. 05.01. Onco.>Bladder C.
2017. 05.03. Pneumo.>Pieris Pharma.
2017. 07.27. Onco. Merck
2017. 08.21. Ethris GmbH
2017. 08.29. Neuro.>PD>MEDI1341
2017. 10.23. Diab.>Exenatide ER
2017. 10.31. Onco.>Lymphoma>MCL
2017. 11.15. Onco.>Breast C.
2017. 11.27. CN FIIF
2018. 02.28. Viela Bio
2018. 04.09. Hepato>NASH>Ionis
2018. 09.14. Onco.>HCL Leukemia
2019. 03.28. Onco.>Daiichi Sankyo
2019. 04.30. BenevolentAI
2019. 05.02. Onco.>TransGene
2019. 06.03. Onco.>Pancreas C.
2019. 06.03. Pancreas C. IL.>Sheba
2019. 06.18. Onco.>Ovarian C. EU>OK
2019. 06.19. Onco.>Ovarian C. JP>OK
2019. 06.19. Pneumo.>COPD>JP>OK
2019. 10.08. Onco.>Lymphoma>MCL
2019. 10.21. type-2 diabetes
2019. 11.21. Onco.>CLL/SLL>AU/CA>OK
2019. 11.21. Onco.>CLL/SLL>USA>OK
2019. 12.05. Onco.>Ovarian C.>CN>OK
2019. 12.20. Onco.>Breast C.
2019. 12.30. Onco.>Pancreas C. USA>
2020. 04.10. Onco.>NF1
2020. 04.30. COVID-19 Vaccine
2020. 05.05. Cardio.>HF>USA>OK
2020. 05.11. Onco.>Ovarian C.
2020. 05.18. Pneumo.>COPD>CN>OK
2020. 05.20. Onco.>Prostate C.>USA>
2020. 05.21. COVID-19 Vaccine
2020. 07.08. Onco.>Pancreas C. EU>O
2020. 07.24. Pneumo.>COPD>USA>OK
2020. 07.27. Onco.>Daiichi Sankyo
2020. 09.17. Dogma Therapeutics
2020. 11.06. Neuro.>Stroke
2020. 11.20. Onco.>durvalumab
2020. 11.25. Onco.>Prostate C.>CA>O
2020. 12.12. Acq. Alexion Pharma.
2020. 12.21. Onco.>Lung C.
2020. 12.28. Onco.>Olaparib>JP>OK
2020. 12.30. COVID-19 Vacc.>USA>EUA
2021. 01.15. Onco.>NSCLC
2021. 01.18. Onco.>Gastric C.
2021. 01.20. Onco.>Breast C.
2021. 06.24. Onco.>Prostate C>CN>OK
2021. 07.08. Onco.>STING Inh>F-Star
2021. 07.23. T2D>GLP-1 RA>USA>OK
2021. 07.27. Obesity Regeneron
2021. 08.02. Rheuma.>SLE>USA>OK
2021. 09.29. Acq. Caelum Bio
2021. 12.08. COVID 19>USA>EUA
2022. 01.13. Scorpion Therapeutics
2022. 02.--. COVID 19>IL>Available
2022. 03.11. Onco.>Breast C. USA>OK
2022. 04.07. Harbour Biomed
2022. 04.14. COVID 19>CA>OK
2022. 05.05. Onco.>Breast C. USA>OK
2022. 07.05. Onco.>Acq. TeneoTwo
2022. 08.05. Onco.>Acalabrutinib>Ta
2022. 08.11. Onco.>Breast C.>CA>OK
2022. 08.25. Neuro.>gMG>JP>OK
2022. 08.25. Onco.>Breast C.>JP>OK
2022. 08.25. Onco.>Lung C.>JP>OK
2022. 09.05. Nephro.>CKD>CN>OK
2022. 09.05. Onco.>BTC>USA>OK
2022. 09.22. Onco.>Ovarian>CN>OK
2022. 10.03. Acq. LogicBio
2022. 10.24. Onco.>Liver>USA>OK
2022. 11.04. Pneumo.>RSV>EU>OK
2022. 11.29. NeoGene Therapeutics
2022. 12.21. Onco.>BTC>EU>OK
2022. 12.21. Onco.>mCRPC>EU>OK
2023. 01.09. Acq. CinCor Pharma
2023. 01.11. Pneumo.>Asthma>USA>OK
2023. 05.09. FDA approval
2023. 06.01. USA Approval
2023. 07.17. USA Approval
2023. 12.12. Acq. Icosavax
2023. 12.26. Acq. Gracell Bio
2024. 01.22. Pneumo.>Asthma>USA>Lau
2024. 02.19. Onco.>NSCLC>USA>OK
2024. 02.22. Acq. Gracell Bio
2024. 03.14. Acq. Amolyt Pharma
2024. 03.19. Acq. Fusion Pharma
2024. 04.01. Hemato.>EVHUSA>OK
2024. 10.07. CV Pipeline with
AstraZeneca Canada Inc/P C2
KuDOS Pharmaceuticals/P C2
Web-Site
Z - OK
AstraZeneca/P C2's products
This section has no products